Source Natural Foods & Herbal Supplements Ltd

SOURCENTRLPharmaceuticals
142.45+0.00 (+0.00%)
As on 29 Jan 2026, 10:35 amMarket Closed

Fundamental Score

...

Source Natural Foods & Herbal Supplements Ltd Share Price Live NSE/BSE

No data
High
0.00
Low
0.00
Volume
0
Change
+0.00%

Profitability Metrics

Poor

Return on Equity

13.87%
Good

Return on Capital Employed

16.64%
Excellent

Operating Profit Margin (5Y)

15.34%
Poor

Dividend Yield

0.00%

Valuation Metrics

Good

Price to Earnings

28.55x

Market Capitalization

85.07 (Cr)

Industry P/E

31.77x

Growth Metrics

Poor

YoY Quarterly Profit Growth

-16.67%
Excellent

YoY Quarterly Sales Growth

65.20%
Excellent

Sales Growth (5Y)

27.01%
Good

EPS Growth (5Y)

12.08%
Good

Profit Growth (5Y)

12.08%

Financial Health

Excellent

Debt to Equity

0.28x
Excellent

Interest Coverage

6.61x
Average

Free Cash Flow (5Y)

6.56 (Cr)

Ownership Structure

Good

Promoter Holding

74.37%
Poor

FII Holding

0.00%
Poor

DII Holding

0.00%
Excellent

Pledged Percentage

0.00%
Market-cap Classification
Small-cap
Higher growth potential with higher volatility.
74.37%
Promoter Holding
85.07 (Cr)
Market Cap

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Market Data Analysis & Educational Insights

Educational evaluation of SOURCENTRL across key market metrics for learning purposes.

Positive Indicators

8 factors identified

Excellent ROCE Performance (16.64%)

Observation: Superior returns on capital employed across business operations.

Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance. This indicates quality business fundamentals.

Strong Operating Margins (15.34%)

Observation: Healthy 5-year operating margins indicate pricing power and cost control.

Analysis: OPM >15% suggests operational efficiency and competitive advantages. This indicates sustainable profitability potential.

Strong Revenue Growth (65.20%)

Observation: Healthy sales growth indicates market demand and execution capability.

Analysis: Revenue growth >15% suggests strong market position and growth potential. This indicates business expansion success.

Consistent Growth Track Record (27.01% CAGR)

Observation: Strong 5-year sales compound annual growth rate.

Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model and market opportunity execution over time.

Conservative Debt Levels (D/E: 0.28)

Observation: Low leverage provides financial flexibility and reduced risk.

Analysis: Conservative debt structure offers resilience during economic downturns and flexibility for growth investments.

Strong Interest Coverage (6.61x)

Observation: Earnings comfortably cover interest obligations.

Analysis: Interest coverage >5x indicates low financial distress risk and strong debt servicing capability.

Balanced Promoter Holding (74.37%)

Observation: Optimal balance between promoter control and public float.

Analysis: Promoter holding in 50-75% range provides management alignment while ensuring adequate liquidity.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral, reducing forced-selling risk.

Analysis: Absence of share pledging eliminates potential forced-selling pressure during market stress.

Risk Factors

3 factors identified

Profit Decline Concern (-16.67%)

Observation: Significant year-over-year profit contraction observed.

Analysis: Declining profitability requires investigation into underlying causes. Monitor for recovery signs and management guidance.

No Dividend Distribution

Observation: Company does not currently pay dividends to shareholders.

Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints. Assess capital allocation strategy.

Small Market Cap

Observation: Higher investment risk due to limited size.

Analysis: Small-cap stocks typically carry higher volatility and liquidity risks.

Financial Statements

Comprehensive financial data for Source Natural Foods & Herbal Supplements Ltd

About SOURCENTRL

Business Overview

Source Natural Foods and Herbal Supplements Limited manufactures and sells ayurveda, health and dietary supplements, and food products in India. The company offers beverages, supplements, arkas, single herbs, and churnas products. It provides healthcare products for ortho, diabetic, digestive, respiratory, skin, heart, liver, kidney care, pain relief, weight loss, mental wellness, immune-modulator and anti-oxidants, natural vitamins and supplements, opthal and ENT care, women's wellness, and hair and scalp health. In addition, the company offers food products, including health drinks, herbal teas, chayawanprash, health powders, masalas and spices, staples and grains, and flours. Further, it engages in renewable energy generation. The company was formerly known as Inwinex Pharmaceuticals Limited and changed its name to Source Natural Foods and Herbal Supplements Limited in June 2012. The company was incorporated in 1995 and is based in Bengaluru, India. Source Natural Foods and Herbal Supplements Limited is a subsidiary of Sriveda Sattva Private Limited.

Company Details

Symbol:SOURCENTRL
Industry:Pharmaceuticals
Sector:Pharmaceuticals

Key Leadership

Mr. Arvind Varchaswi Narasimhan
MD & Executive Non-Independent Director
Mr. R. Ramachandra
Chief Financial Officer
Mr. Yash Jain
Compliance Officer & Company Secretary

Corporate Events

Recent
Ex-Dividend Date
2019-09-12

SOURCENTRL Stock Details & Analysis

Key Financial Metrics

Return on Equity (ROE)13.87%
Return on Capital Employed16.64%
Operating Profit Margin (5Y)15.34%
Debt to Equity Ratio0.28
Interest Coverage Ratio6.61

Growth & Valuation

Sales Growth (5Y)27.01%
Profit Growth (5Y)12.08%
EPS Growth (5Y)12.08%
YoY Quarterly Profit Growth-16.67%
YoY Quarterly Sales Growth65.20%

Frequently Asked Questions

What is the current price of Source Natural Foods & Herbal Supplements Ltd (SOURCENTRL)?

As of 29 Jan 2026, 10:35 am IST, Source Natural Foods & Herbal Supplements Ltd (SOURCENTRL) is currently trading at ₹142.45. The stock has a market capitalization of ₹85.07 (Cr).

Is SOURCENTRL share price Overvalued or Undervalued?

SOURCENTRL is currently trading at a P/E ratio of 28.55x, compared to the industry average of 31.77x. Based on this relative valuation, the stock appears to be Undervalued against its sector peers.

What factors affect the Source Natural Foods & Herbal Supplements Ltd share price?

Key factors influencing SOURCENTRL's price include its quarterly earnings growth (Sales Growth: 65.20%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).

Is Source Natural Foods & Herbal Supplements Ltd a good stock for long-term investment?

Source Natural Foods & Herbal Supplements Ltd shows a 5-year Profit Growth of 12.08% and an ROE of 13.87%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.28 before investing.

How does Source Natural Foods & Herbal Supplements Ltd compare with its industry peers?

Source Natural Foods & Herbal Supplements Ltd competes with major peers in the Pharmaceuticals. Investors should compare SOURCENTRL's P/E of 28.55x and ROE of 13.87% against the industry averages to determine its competitive standing.

What is the P/E ratio of SOURCENTRL and what does it mean?

SOURCENTRL has a P/E ratio of 28.55x compared to the industry average of 31.77x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹29 for every ₹1 of annual earnings.

How is SOURCENTRL performing according to Bull Run's analysis?

SOURCENTRL has a Bull Run fundamental score of 54.6/100, which indicates moderate strength with some areas for improvement. This comprehensive rating is based on 15+ financial parameters including profitability, growth metrics, and valuation ratios.

What sector and industry does SOURCENTRL belong to?

SOURCENTRL operates in the Pharmaceuticals industry. This classification helps understand the competitive landscape and sector-specific trends affecting Source Natural Foods & Herbal Supplements Ltd.

What is Return on Equity (ROE) and why is it important for SOURCENTRL?

SOURCENTRL has an ROE of 13.87%, which shows decent profitability but room for improvement. Return on Equity measures how efficiently Source Natural Foods & Herbal Supplements Ltd generates profits from shareholders' equity.

How is SOURCENTRL's debt-to-equity ratio and what does it indicate?

SOURCENTRL has a debt-to-equity ratio of 0.28, which indicates conservative financing with low financial risk. A ratio below 1.0 generally indicates conservative financing.

What is SOURCENTRL's dividend yield and is it a good dividend stock?

SOURCENTRL offers a dividend yield of 0.00%, which means you receive ₹0.00 annual dividend for every ₹100 invested.

How has SOURCENTRL grown over the past 5 years?

SOURCENTRL has achieved 5-year growth rates of: Sales Growth 27.01%, Profit Growth 12.08%, and EPS Growth 12.08%.

What is the promoter holding in SOURCENTRL and why does it matter?

Promoters hold 74.37% of SOURCENTRL shares, with 0.00% of promoter shares pledged. High promoter holding often indicates strong management confidence.

What is SOURCENTRL's market capitalization category?

SOURCENTRL has a market capitalization of ₹85 crores, placing it in the Small-cap category.

How volatile is SOURCENTRL stock?

SOURCENTRL has a beta of N/A. A beta > 1 suggests the stock is more volatile than the market, while a beta < 1 suggests it is less volatile.

What is the 52-week high and low for SOURCENTRL?

SOURCENTRL has a 52-week high of ₹N/A and low of ₹N/A.

What is SOURCENTRL's operating profit margin trend?

SOURCENTRL has a 5-year average Operating Profit Margin (OPM) of 15.34%, indicating the company's operational efficiency.

How is SOURCENTRL's quarterly performance?

Recent quarterly performance shows YoY Sales Growth of 65.20% and YoY Profit Growth of -16.67%.

What is the institutional holding pattern in SOURCENTRL?

SOURCENTRL has FII holding of 0.00% and DII holding of 0.00%. Significant institutional holding often suggests professional confidence in the stock.